Standard BioTools Inc. (FLDM)
NASDAQ: FLDM
· Real-Time Price · USD
3.71
-0.28 (-7.02%)
At close: Apr 06, 2022, 6:00 AM
Standard BioTools Revenue Breakdown
| Period Ending | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Collaboration Revenue Revenue | 2M | 90K | 914K | 1.48M | 2.69M | 3.18M | 3M | 18.98M | 20.67M | 23.23M | 5.28M | 69.41M | 24.24M |
| Collaboration Revenue Revenue Growth | +2121.11% | -90.15% | -38.24% | -44.88% | -15.57% | +6.00% | -84.19% | -8.15% | -11.06% | +339.72% | -92.39% | +186.31% | n/a |
| Product and Service, Other Revenue | 1.43M | 461K | 22.63M | 300K | 4.9M | 1.34M | 513K | 5.19M | 5.63M | 4.96M | n/a | n/a | n/a |
| Product and Service, Other Revenue Growth | +209.98% | -97.96% | +7442.33% | -93.88% | +265.90% | +161.21% | -90.11% | -7.89% | +13.49% | n/a | n/a | n/a | n/a |
| Product Revenue | 75.65M | 21.94M | 6.63M | 24.73M | 34.35M | 29.21M | 17.41M | n/a | n/a | n/a | n/a | n/a | n/a |
| Product Revenue Growth | +244.84% | +231.02% | -73.20% | -28.01% | +17.59% | +67.83% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Service Revenue | 19.63M | 6.02M | n/a | 6.29M | 6.12M | 6.13M | 5.14M | n/a | n/a | n/a | n/a | n/a | n/a |
| Service Revenue Growth | +226.31% | n/a | n/a | +2.68% | -0.15% | +19.28% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Americas Revenue | 45.35M | 13.01M | 16.12M | 18.52M | 22.15M | 23.65M | 13.94M | 14.84M | 11.11M | 11.12M | 12.97M | 16.98M | 8.2M | 2.32M | 2.78M | 3.33M | 3.38M | 2.79M | 4.61M | 2.09M | 4.1M | 897K | 1.57M |
| Americas Revenue Growth | +248.53% | -19.27% | -12.97% | -16.37% | -6.36% | +69.68% | -6.09% | +33.59% | -0.07% | -14.27% | -23.61% | +107.20% | +253.84% | -16.75% | -16.51% | -1.48% | +21.13% | -39.46% | +120.46% | -48.99% | +357.19% | -42.72% | n/a |
| Asia Pacific Revenue | 18.85M | 5.38M | 5.68M | 5.13M | 8.17M | 7.37M | 5.56M | 4.68M | 6.29M | 5.86M | 8.98M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Asia Pacific Revenue Growth | +250.23% | -5.20% | +10.70% | -37.24% | +10.88% | +32.55% | +18.90% | -25.67% | +7.39% | -34.78% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Emea Revenue | 33.58M | 10.11M | 9.22M | 9.14M | 14.29M | 8.84M | 6.56M | 8.1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Emea Revenue Growth | +232.21% | +9.63% | +0.85% | -36.01% | +61.66% | +34.77% | -19.01% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 30.88M | 22.96M | 24.07M | 24.25M | 27.61M | 31.93M | 22.66M | 20.62M | 22.7M | 18.79M | 20.73M | 22.13M | 22.82M | 21.97M | 20.02M | 18.99M | 18.8M | 15.86M | 20.1M | 20.98M | 22.58M | 22.77M | 21.12M | 23.84M | 25.48M | 22.09M | 19.56M | 21.22M | 20.09M |
| Selling, General, and Administrative Revenue Growth | +34.47% | -4.62% | -0.73% | -12.17% | -13.55% | +40.96% | +9.89% | -9.16% | +20.78% | -9.35% | -6.35% | -3.02% | +3.88% | +9.75% | +5.44% | +0.97% | +18.55% | -21.09% | -4.16% | -7.09% | -0.84% | +7.79% | -11.42% | -6.40% | +15.35% | +12.92% | -7.84% | +5.61% | n/a |
| Research and Development Revenue | 8.87M | 8.54M | 9.21M | 9.44M | 10.75M | 11.19M | 8.13M | 8.45M | 8.7M | 8.28M | 7.13M | 7.87M | 8.37M | 7.96M | 7.43M | 7.39M | 7.26M | 7.16M | 7.68M | 7.46M | 8.52M | 8.77M | 9.25M | 9.98M | 10.41M | 9.74M | 9.44M | 10.09M | 9.99M |
| Research and Development Revenue Growth | +3.79% | -7.25% | -2.46% | -12.20% | -3.87% | +37.62% | -3.79% | -2.89% | +5.09% | +16.18% | -9.41% | -6.06% | +5.20% | +7.11% | +0.60% | +1.79% | +1.37% | -6.83% | +2.98% | -12.47% | -2.84% | -5.18% | -7.28% | -4.17% | +6.90% | +3.13% | -6.40% | +1.00% | n/a |